The Erythropoietin Promoter Variant Rs1617640 is Not Associated with Severe Retinopathy of Prematurity, Independent of Treatment with Erythropoietin
The journal of pediatrics/The Journal of pediatrics(2018)
Abstract
In this case-control study, the erythropoietin (EPO) promoter variant s1617640, linked to high intravitreal EPO concentrations and increased risk of diabetic retinopathy, was not associated with severe retinopathy of prematurity. This finding was observed both in infants with and without recombinant EPO administration.
MoreTranslated text
Key words
ROP,EPO,PCR,rEPO,VLBW
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined